Gilles Favre Selected Research

MicroRNAs (MicroRNA)

1/2016

Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilles Favre Research Topics

Disease

46	Neoplasms (Cancer) 01/2021 - 09/2002
13	Melanoma (Melanoma, Malignant) 02/2019 - 07/2004
11	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2003
10	Lung Neoplasms (Lung Cancer) 05/2020 - 04/2004
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 11/2009
8	Carcinogenesis 01/2021 - 04/2004
5	Neoplasm Metastasis (Metastasis) 01/2019 - 11/2009
5	Glioblastoma (Glioblastoma Multiforme) 06/2013 - 12/2003
5	Glioma (Gliomas) 04/2009 - 07/2002
4	Hypoxia (Hypoxemia) 02/2015 - 12/2003
3	Adenocarcinoma of Lung 01/2020 - 01/2016
3	Genomic Instability 11/2019 - 08/2014
3	Circulating Neoplastic Cells 01/2018 - 01/2016
3	Ovarian Neoplasms (Ovarian Cancer) 04/2010 - 01/2008
2	Disease Progression 01/2020 - 02/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 02/2016
2	Hypersensitivity (Allergy) 06/2015 - 01/2014
2	Atherosclerosis 10/2006 - 03/2004
1	Residual Neoplasm 03/2020
1	Adenocarcinoma 12/2014
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2014
1	Oncogene Addiction 02/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2006
8	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2014
8	Monomeric GTP-Binding ProteinsIBA 07/2019 - 12/2003
7	Biomarkers (Surrogate Marker)IBA 11/2019 - 09/2010
5	Guanosine Triphosphate (GTP)IBA 01/2021 - 03/2008
5	Tamoxifen FDA LinkGeneric 02/2010 - 09/2003
5	TransferasesIBA 02/2010 - 09/2003
4	Tyrosine Kinase InhibitorsIBA 05/2022 - 01/2017
4	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2021 - 02/2008
4	GTP Phosphohydrolases (GTPases)IBA 01/2019 - 09/2010
4	Farnesyltranstransferase (Farnesyltransferase)IBA 06/2013 - 07/2002
4	tipifarnib (R115777)IBA 06/2013 - 07/2002
4	Estrogen ReceptorsIBA 01/2013 - 11/2004
3	Messenger RNA (mRNA)IBA 07/2019 - 07/2012
3	LigandsIBA 03/2017 - 08/2004
3	Pharmaceutical PreparationsIBA 08/2014 - 07/2002
3	Small Interfering RNA (siRNA)IBA 01/2014 - 01/2006
3	IntegrinsIBA 06/2013 - 07/2008
3	Biological ProductsIBA 11/2009 - 12/2003
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2009 - 09/2002
2	ErbB Receptors (EGF Receptor)IBA 05/2022 - 06/2012
2	Circulating Tumor DNAIBA 05/2020 - 01/2016
2	Cell-Free Nucleic AcidsIBA 03/2020 - 10/2016
2	AntibodiesIBA 02/2019 - 03/2008
2	micaIBA 03/2017 - 01/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017 - 06/2011
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 02/2016 - 08/2014
2	Monoclonal AntibodiesIBA 01/2016 - 08/2015
2	AntigensIBA 01/2016 - 12/2005
2	RNA (Ribonucleic Acid)IBA 01/2016 - 04/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2015 - 02/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2013 - 12/2007
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2012 - 02/2010
2	Hormones (Hormone)IBA 02/2010 - 09/2003
2	Histocompatibility Antigens Class IIBA 02/2010 - 12/2005
2	CholesterolIBA 08/2004 - 03/2004
2	Selective Estrogen Receptor Modulators (SERM)IBA 08/2004 - 03/2004
1	Diphosphonates (Bisphosphonates)IBA 01/2020
1	osimertinibIBA 01/2020
1	Gefitinib (Iressa)FDA Link 01/2020
1	Immune Checkpoint InhibitorsIBA 11/2019
1	Antineoplastic Agents (Antineoplastics)IBA 07/2019
1	Decitabine FDA Link 01/2019
1	A-Form DNA (A-DNA)IBA 01/2019
1	Cadherins (E-Cadherin)IBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	NivolumabIBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Threonine (L-Threonine)FDA Link 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 03/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2016
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 03/2016
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 03/2016
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2016
1	Circulating MicroRNAIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 08/2015
1	Chemokine CXCL12IBA 08/2015
1	VemurafenibIBA 06/2015
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	Oxygen (Dioxygen)IBA 02/2015
1	fasudil (AT 877)IBA 01/2015
1	Fas Ligand Protein (Fas Ligand)IBA 01/2015
1	fas Receptor (CD95 Antigen)IBA 01/2015
1	CamptothecinIBA 08/2014
1	Histones (Histone)IBA 01/2014
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 06/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	Mevalonic Acid (Mevalonate)IBA 01/2013
1	Staphylococcal Protein A (Protein A)IBA 01/2013

Therapy/Procedure

12	Therapeutics 05/2022 - 09/2003
5	Radiotherapy 06/2013 - 12/2003
4	Immunotherapy 05/2020 - 01/2013
4	Drug Therapy (Chemotherapy) 01/2020 - 04/2004
2	Precision Medicine 10/2016 - 02/2015
1	Aftercare (After-Treatment) 01/2021
1	Intravenous Injections 01/2015